Ethnic Differences in Hematologic Toxicity from Imatinib in Patients with Gastrointestinal Stromal Cell Tumor (GIST): Coincidence or a Real Phenomenon

OBJECTIVES: There is a wide variability in the pharmacokinetics, pharmacodynamics and tolerance of anticancer drugs based on ethnicity. GIST is a rare cancer, (~1% of GI cancers). Imatinib is used in the neo-adjuvant, adjuvant and metastatic setting. The purpose of this study was to report the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saif, Muhammad Wasif, Purvey, Sneha, Kaley, Kristin, Wasif, Nawal, Carmel, Annmarie, Rodriguez, Teresa, Miller, Kenneth B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043204/
https://www.ncbi.nlm.nih.gov/pubmed/32104790
http://dx.doi.org/10.14744/ejmo.2019.94710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043204/
https://www.ncbi.nlm.nih.gov/pubmed/32104790
http://dx.doi.org/10.14744/ejmo.2019.94710

Ejemplares similares